Edition:
United States

Dechra Pharmaceuticals PLC (DPH.L)

DPH.L on London Stock Exchange

2,062.00GBp
16 Nov 2018
Change (% chg)

-50.00 (-2.37%)
Prev Close
2,112.00
Open
2,118.00
Day's High
2,136.00
Day's Low
2,054.00
Volume
77,109
Avg. Vol
403,276
52-wk High
3,180.48
52-wk Low
1,956.00

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Jun-18 5 408.06 411.00 405.70 --
Year Ending Jun-19 7 461.64 465.00 455.86 430.58
Year Ending Jun-20 7 501.57 519.00 485.40 470.61
Earnings (per share)
Year Ending Jun-18 5 75.32 78.17 71.74 --
Year Ending Jun-19 7 86.13 87.82 84.00 82.17
Year Ending Jun-20 7 98.75 102.93 93.34 91.89
Sales and Profit Figures in British Pound (GBP);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 79.67 28.12 29.34
P/E High - Last 5 Yrs. 103.87 41.51 45.80
P/E Low - Last 5 Yrs. 32.68 24.62 25.31
Beta 0.49 0.93 0.91
Price to Sales (TTM) 5.43 19.20 20.58
Price to Book (MRQ) 4.37 4.02 4.23
Price to Tangible Book (MRQ) -- 13.41 12.85
Price to Cash Flow (TTM) 26.00 20.65 21.19
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 1.74 1.65
Dividend Yield - 5 Year Avg 1.33 1.50 1.43
Dividend 5 Year Growth Rate 12.74 -10.81 -8.12
Payout Ratio(TTM) 100.00 45.76 43.70

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 14.06 4.85 6.75
Sales (TTM) vs TTM 1 Yr. Ago 13.31 4.07 5.37
Sales - 5 Yr. Growth Rate 16.56 7.00 7.49
EPS (MRQ) vs Qtr. 1 Yr. Ago -42.64 31.24 28.07
EPS (TTM) vs TTM 1 Yr. Ago -3.06 -- --
EPS - 5 Yr. Growth Rate 16.68 6.67 7.60
Capital Spending - 5 Yr. Growth Rate 6.68 7.91 8.20

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 1.76 2.62 2.61
Current Ratio (MRQ) 2.71 3.66 3.62
LT Debt to Equity (MRQ) 57.41 7.92 9.93
Total Debt to Equity (MRQ) 57.64 11.50 13.83
Interest Coverage (TTM) 16.00 40.74 35.65

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 55.88 53.90 53.45
Gross Margin - 5 Yr. Avg. 55.69 52.31 52.35
EBITD Margin (TTM) 36.87 -- --
EBITD - 5 Yr. Avg 24.43 18.40 16.19
Operating Margin (TTM) 8.50 11.92 -12.21
Operating Margin - 5 Yr. Avg. 9.50 14.38 11.73
Pre-Tax Margin (TTM) 7.10 12.58 -10.76
Pre-Tax Margin - 5 Yr. Avg. 8.45 14.78 12.03
Net Profit Margin (TTM) 6.41 9.06 -14.16
Net Profit Margin - 5 Yr. Avg. 7.34 11.01 8.29
Effective Tax Rate (TTM) 9.69 21.94 21.78
Effective Tax Rate - 5 Yr. Avg. 13.13 23.86 24.36

Efficiency

  Company industry sector
Revenue/Employee (TTM) 283,298 952,877,148 844,001,767
Net Income/Employee (TTM) 18,163 111,163,364 98,323,451
Receivable Turnover (TTM) 5.47 5.36 5.42
Inventory Turnover (TTM) 2.51 2.70 4.00
Asset Turnover (TTM) 0.49 0.93 0.91

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 3.15 11.32 10.84
Return on Assets - 5 Yr. Avg. 4.14 12.15 11.60
Return on Investment (TTM) 3.49 14.10 13.58
Return on Investment - 5 Yr. Avg. 4.73 15.60 14.86
Return on Equity (TTM) 6.48 15.67 15.11
Return on Equity - 5 Yr. Avg. 7.89 16.62 16.02
  1 Year 3 Year 5 Year
Sales % 13.31 26.01 16.56
EPS (TTM) % -4.09 6.80 16.68
Dividend % 18.94 14.61 12.74
Note: Units in Millions of US Dollars

Performance for Dechra Pharmaceuticals PLC

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 2.67 2.96 99 88
13 Week -31.64 -26.24 18 94
26 Week -22.00 -14.59 64 89
52 Week 0.28 5.30 99 59
YTD 2.86 12.10 99 57
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 84.37%
# of Holders: 183
Total Shares Held: 86,478,547
3 Mo. Net Change: 1,265,470
# New Positions: 14
# Closed Positions: 16
# Increased Positions: 45
# Reduced Positions: 41
# Net Buyers: 4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.